info iconCurrently, the share price for Akums Drugs & Pharmaceuticals Ltd. is delayed.

close icon

Akums Drugs & Pharmaceuticals Ltd.

₹580.45
NSE
--   ( -- %) 1D



  • Prev. Close
    580.45
  • Upper Circuit
    636.35
  • Lower Circuit
    520.65

Analyst Sentiment For Akums Drugs & Pharmaceuticals Ltd.

Info icon
There seem to be no recommendations on this stock from the analyst universe covered

Returns

Akums Drugs & Pharmaceuticals Ltd.'s Info & Management

Akums Drugs & Pharmaceuticals is engaged in contract manufacturing which involves manufacturing of pharmaceutical formulations and specializes in developing new formulations, undertaking bio equivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Company's own technology to its customers under their brand names.
  • Chief Financial Officer
    Mr. Sumeet Sood
  • Executive Director,Whole Time Director,President
    Sanjay Sinha
  • Company Secretary,Compliance Officer
    DHARAMVIR MALIK
  • President(Human Resources)
    Mr. Arvind Srivastava
  • President(Strategy,New Projects,Business Excellence)
    Mr. Sanjay Sharma
  • Vice President(R & D)
    Mr. Sunil Jaiswal

FAQs on Akums Drugs & Pharmaceuticals Ltd.

What is the share price of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
Akums Drugs & Pharmaceuticals Ltd. share price is ₹578.85 as of July 4, 2025, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
The 52-week high and low of Akums Drugs & Pharmaceuticals Ltd. is ₹1,175.90 and ₹407.15 respectively as of July 4, 2025, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
The trailing twelve month (TTM) PB ratio of Akums Drugs & Pharmaceuticals Ltd. is 2.91 as of July 6, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
The Upper Circuit of Akums Drugs & Pharmaceuticals Ltd. is ₹636. The Lower Circuit of Akums Drugs & Pharmaceuticals Ltd. is ₹521.

What is the ROE of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
Akums Drugs & Pharmaceuticals Ltd. reported an ROE of 18.00% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Akums Drugs & Pharmaceuticals Ltd., Promoter held 75.3%, the FII held 5.8%, DII held 7.4% and the public held 8.8% of the total shares.

How to buy Akums Drugs & Pharmaceuticals Ltd. Share?

down-arrow
You can easily buy shares of Akums Drugs & Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Akums Drugs & Pharmaceuticals Ltd.?

down-arrow
The fair value of Akums Drugs & Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer